Cellular consequences of the expression of Alzheimer's disease-causing presenilin 1 mutations in human neuroblastoma (SH-SY5Y) cells

Abstract Mutations in the presenilin 1 (PS1) gene lead to early-onset Alzheimer's disease with the S170F mutation causing the earliest reported age of onset. Expression of this, and other PS1 mutations, in SH-SY5Y cells resulted in significant loss of cellular viability compared to control cell...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Brain research 2012-03, Vol.1443, p.75-88
Hauptverfasser: Boyle, John P, Hettiarachchi, Nishani T, Wilkinson, Jenny A, Pearson, Hugh A, Scragg, Jason L, Lendon, Corinne, Al-Owais, Moza M, Kim, Cindy B, Myers, David M, Warburton, Philip, Peers, Chris
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 88
container_issue
container_start_page 75
container_title Brain research
container_volume 1443
creator Boyle, John P
Hettiarachchi, Nishani T
Wilkinson, Jenny A
Pearson, Hugh A
Scragg, Jason L
Lendon, Corinne
Al-Owais, Moza M
Kim, Cindy B
Myers, David M
Warburton, Philip
Peers, Chris
description Abstract Mutations in the presenilin 1 (PS1) gene lead to early-onset Alzheimer's disease with the S170F mutation causing the earliest reported age of onset. Expression of this, and other PS1 mutations, in SH-SY5Y cells resulted in significant loss of cellular viability compared to control cells. Basal Ca 2 + concentrations in PS1 mutants were never lower than controls and prolonged incubation in Ca 2 + -free solutions did not deplete Ca 2 + stores, demonstrating there was no difference in Ca 2 + leak from endoplasmic reticulum (ER) stores in PS1 mutants. Peak muscarine-evoked rises of [Ca 2 + ]i were variable, but the integrals were not significantly different, suggesting, while kinetics of Ca 2 + store release might be affected in PS1 mutants, store size was similar. However, when Ca 2 + -ATPase activity was irreversibly inhibited with thapsigargin, the S170F and ΔE9 cells showed larger capacitative calcium entry indicating a direct effect on Ca 2 + influx pathways. There was no significant effect of any of the mutations on mitochondrial respiration. Amyloid β(Aβ(1–40)) secretion was reduced, and Aβ(1–42) secretion increased in the S170F cells resulting in a very large increase in the Aβ42/40 ratio. This, rather than any potential disruption of ER Ca 2 + stores, is likely to explain the extreme pathology of this mutant.
doi_str_mv 10.1016/j.brainres.2011.12.061
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_926507123</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0006899312000042</els_id><sourcerecordid>926507123</sourcerecordid><originalsourceid>FETCH-LOGICAL-c476t-63c27808edb5bbb61814daf8eb2bde4a90ef9193bc5157b18e4daf9d7e56503</originalsourceid><addsrcrecordid>eNqFkk1v1DAQhiMEoqXwF4ovqHDIYjuJHV8Q1QooUiUOC4eeLNuZdL0k9uJJEOXMD8fRbkHiwslfz8w7fmeK4pzRFaNMvN6tbDI-JMAVp4ytGF9RwR4Up6yVvBS8pg-LU0qpKFulqpPiCeIuH6tK0cfFCedcSSb5afFrDcMwDyYRFwPCtxmCAySxJ9MWCPzYZwX0MSw3l8PPLfgR0gWSziMYhNKZGX24JQsHwQ8-EEbGeTJTDkKSj9t5NIEEmFO0g8Epjoa83FyVm5vm5hVxWR6fFo96MyA8O65nxeb9u8_rq_L604eP68vr0tVSTKWoHJctbaGzjbVWsJbVnelbsNx2UBtFoVdMVdY1rJGWtbA8q05CIxpanRUXh6z7FPM_cdKjx0XfBIgzasUzJRmvMikOpEsRMUGv98mPJt1pRvViv97pe_v1Yr9mXGf7c-D5UWK2I3R_wu79zsCLI2DQmaFPJjiPf7lGVFIxmbnnB643UZvblJkvm6zU5B6qmkmRibcHArJh3z0kjc4vzet8AjfpLvr_V_vmnxQu98_nur7CHeAuzinkdmimMQfozTJOyzQxnne05tVv-nTG7Q</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>926507123</pqid></control><display><type>article</type><title>Cellular consequences of the expression of Alzheimer's disease-causing presenilin 1 mutations in human neuroblastoma (SH-SY5Y) cells</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Boyle, John P ; Hettiarachchi, Nishani T ; Wilkinson, Jenny A ; Pearson, Hugh A ; Scragg, Jason L ; Lendon, Corinne ; Al-Owais, Moza M ; Kim, Cindy B ; Myers, David M ; Warburton, Philip ; Peers, Chris</creator><creatorcontrib>Boyle, John P ; Hettiarachchi, Nishani T ; Wilkinson, Jenny A ; Pearson, Hugh A ; Scragg, Jason L ; Lendon, Corinne ; Al-Owais, Moza M ; Kim, Cindy B ; Myers, David M ; Warburton, Philip ; Peers, Chris</creatorcontrib><description>Abstract Mutations in the presenilin 1 (PS1) gene lead to early-onset Alzheimer's disease with the S170F mutation causing the earliest reported age of onset. Expression of this, and other PS1 mutations, in SH-SY5Y cells resulted in significant loss of cellular viability compared to control cells. Basal Ca 2 + concentrations in PS1 mutants were never lower than controls and prolonged incubation in Ca 2 + -free solutions did not deplete Ca 2 + stores, demonstrating there was no difference in Ca 2 + leak from endoplasmic reticulum (ER) stores in PS1 mutants. Peak muscarine-evoked rises of [Ca 2 + ]i were variable, but the integrals were not significantly different, suggesting, while kinetics of Ca 2 + store release might be affected in PS1 mutants, store size was similar. However, when Ca 2 + -ATPase activity was irreversibly inhibited with thapsigargin, the S170F and ΔE9 cells showed larger capacitative calcium entry indicating a direct effect on Ca 2 + influx pathways. There was no significant effect of any of the mutations on mitochondrial respiration. Amyloid β(Aβ(1–40)) secretion was reduced, and Aβ(1–42) secretion increased in the S170F cells resulting in a very large increase in the Aβ42/40 ratio. This, rather than any potential disruption of ER Ca 2 + stores, is likely to explain the extreme pathology of this mutant.</description><identifier>ISSN: 0006-8993</identifier><identifier>EISSN: 1872-6240</identifier><identifier>DOI: 10.1016/j.brainres.2011.12.061</identifier><identifier>PMID: 22297172</identifier><identifier>CODEN: BRREAP</identifier><language>eng</language><publisher>Amsterdam: Elsevier B.V</publisher><subject>Adult and adolescent clinical studies ; Alzheimer disease ; Alzheimer's disease ; amyloid ; Amyloid beta-Peptides - metabolism ; Amyloid β mitochondria ; Biological and medical sciences ; brain ; Ca2 + homeostasis ; calcium ; Calcium - metabolism ; Cell Line, Tumor ; Cell Survival ; Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases ; endoplasmic reticulum ; genes ; Humans ; Medical sciences ; Mitochondria - metabolism ; mutants ; Mutation ; Neurology ; Organic mental disorders. Neuropsychology ; Presenilin-1 - genetics ; Presenilin-1 - metabolism ; Psychology. Psychoanalysis. Psychiatry ; Psychopathology. Psychiatry ; S170F PS1 mutation ; secretion ; SH-SY5Y ; viability</subject><ispartof>Brain research, 2012-03, Vol.1443, p.75-88</ispartof><rights>Elsevier B.V.</rights><rights>2012 Elsevier B.V.</rights><rights>2015 INIST-CNRS</rights><rights>Copyright © 2012 Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c476t-63c27808edb5bbb61814daf8eb2bde4a90ef9193bc5157b18e4daf9d7e56503</citedby><cites>FETCH-LOGICAL-c476t-63c27808edb5bbb61814daf8eb2bde4a90ef9193bc5157b18e4daf9d7e56503</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0006899312000042$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=25637917$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22297172$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Boyle, John P</creatorcontrib><creatorcontrib>Hettiarachchi, Nishani T</creatorcontrib><creatorcontrib>Wilkinson, Jenny A</creatorcontrib><creatorcontrib>Pearson, Hugh A</creatorcontrib><creatorcontrib>Scragg, Jason L</creatorcontrib><creatorcontrib>Lendon, Corinne</creatorcontrib><creatorcontrib>Al-Owais, Moza M</creatorcontrib><creatorcontrib>Kim, Cindy B</creatorcontrib><creatorcontrib>Myers, David M</creatorcontrib><creatorcontrib>Warburton, Philip</creatorcontrib><creatorcontrib>Peers, Chris</creatorcontrib><title>Cellular consequences of the expression of Alzheimer's disease-causing presenilin 1 mutations in human neuroblastoma (SH-SY5Y) cells</title><title>Brain research</title><addtitle>Brain Res</addtitle><description>Abstract Mutations in the presenilin 1 (PS1) gene lead to early-onset Alzheimer's disease with the S170F mutation causing the earliest reported age of onset. Expression of this, and other PS1 mutations, in SH-SY5Y cells resulted in significant loss of cellular viability compared to control cells. Basal Ca 2 + concentrations in PS1 mutants were never lower than controls and prolonged incubation in Ca 2 + -free solutions did not deplete Ca 2 + stores, demonstrating there was no difference in Ca 2 + leak from endoplasmic reticulum (ER) stores in PS1 mutants. Peak muscarine-evoked rises of [Ca 2 + ]i were variable, but the integrals were not significantly different, suggesting, while kinetics of Ca 2 + store release might be affected in PS1 mutants, store size was similar. However, when Ca 2 + -ATPase activity was irreversibly inhibited with thapsigargin, the S170F and ΔE9 cells showed larger capacitative calcium entry indicating a direct effect on Ca 2 + influx pathways. There was no significant effect of any of the mutations on mitochondrial respiration. Amyloid β(Aβ(1–40)) secretion was reduced, and Aβ(1–42) secretion increased in the S170F cells resulting in a very large increase in the Aβ42/40 ratio. This, rather than any potential disruption of ER Ca 2 + stores, is likely to explain the extreme pathology of this mutant.</description><subject>Adult and adolescent clinical studies</subject><subject>Alzheimer disease</subject><subject>Alzheimer's disease</subject><subject>amyloid</subject><subject>Amyloid beta-Peptides - metabolism</subject><subject>Amyloid β mitochondria</subject><subject>Biological and medical sciences</subject><subject>brain</subject><subject>Ca2 + homeostasis</subject><subject>calcium</subject><subject>Calcium - metabolism</subject><subject>Cell Line, Tumor</subject><subject>Cell Survival</subject><subject>Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases</subject><subject>endoplasmic reticulum</subject><subject>genes</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>Mitochondria - metabolism</subject><subject>mutants</subject><subject>Mutation</subject><subject>Neurology</subject><subject>Organic mental disorders. Neuropsychology</subject><subject>Presenilin-1 - genetics</subject><subject>Presenilin-1 - metabolism</subject><subject>Psychology. Psychoanalysis. Psychiatry</subject><subject>Psychopathology. Psychiatry</subject><subject>S170F PS1 mutation</subject><subject>secretion</subject><subject>SH-SY5Y</subject><subject>viability</subject><issn>0006-8993</issn><issn>1872-6240</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkk1v1DAQhiMEoqXwF4ovqHDIYjuJHV8Q1QooUiUOC4eeLNuZdL0k9uJJEOXMD8fRbkHiwslfz8w7fmeK4pzRFaNMvN6tbDI-JMAVp4ytGF9RwR4Up6yVvBS8pg-LU0qpKFulqpPiCeIuH6tK0cfFCedcSSb5afFrDcMwDyYRFwPCtxmCAySxJ9MWCPzYZwX0MSw3l8PPLfgR0gWSziMYhNKZGX24JQsHwQ8-EEbGeTJTDkKSj9t5NIEEmFO0g8Epjoa83FyVm5vm5hVxWR6fFo96MyA8O65nxeb9u8_rq_L604eP68vr0tVSTKWoHJctbaGzjbVWsJbVnelbsNx2UBtFoVdMVdY1rJGWtbA8q05CIxpanRUXh6z7FPM_cdKjx0XfBIgzasUzJRmvMikOpEsRMUGv98mPJt1pRvViv97pe_v1Yr9mXGf7c-D5UWK2I3R_wu79zsCLI2DQmaFPJjiPf7lGVFIxmbnnB643UZvblJkvm6zU5B6qmkmRibcHArJh3z0kjc4vzet8AjfpLvr_V_vmnxQu98_nur7CHeAuzinkdmimMQfozTJOyzQxnne05tVv-nTG7Q</recordid><startdate>20120314</startdate><enddate>20120314</enddate><creator>Boyle, John P</creator><creator>Hettiarachchi, Nishani T</creator><creator>Wilkinson, Jenny A</creator><creator>Pearson, Hugh A</creator><creator>Scragg, Jason L</creator><creator>Lendon, Corinne</creator><creator>Al-Owais, Moza M</creator><creator>Kim, Cindy B</creator><creator>Myers, David M</creator><creator>Warburton, Philip</creator><creator>Peers, Chris</creator><general>Elsevier B.V</general><general>Elsevier</general><scope>FBQ</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20120314</creationdate><title>Cellular consequences of the expression of Alzheimer's disease-causing presenilin 1 mutations in human neuroblastoma (SH-SY5Y) cells</title><author>Boyle, John P ; Hettiarachchi, Nishani T ; Wilkinson, Jenny A ; Pearson, Hugh A ; Scragg, Jason L ; Lendon, Corinne ; Al-Owais, Moza M ; Kim, Cindy B ; Myers, David M ; Warburton, Philip ; Peers, Chris</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c476t-63c27808edb5bbb61814daf8eb2bde4a90ef9193bc5157b18e4daf9d7e56503</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Adult and adolescent clinical studies</topic><topic>Alzheimer disease</topic><topic>Alzheimer's disease</topic><topic>amyloid</topic><topic>Amyloid beta-Peptides - metabolism</topic><topic>Amyloid β mitochondria</topic><topic>Biological and medical sciences</topic><topic>brain</topic><topic>Ca2 + homeostasis</topic><topic>calcium</topic><topic>Calcium - metabolism</topic><topic>Cell Line, Tumor</topic><topic>Cell Survival</topic><topic>Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases</topic><topic>endoplasmic reticulum</topic><topic>genes</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>Mitochondria - metabolism</topic><topic>mutants</topic><topic>Mutation</topic><topic>Neurology</topic><topic>Organic mental disorders. Neuropsychology</topic><topic>Presenilin-1 - genetics</topic><topic>Presenilin-1 - metabolism</topic><topic>Psychology. Psychoanalysis. Psychiatry</topic><topic>Psychopathology. Psychiatry</topic><topic>S170F PS1 mutation</topic><topic>secretion</topic><topic>SH-SY5Y</topic><topic>viability</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Boyle, John P</creatorcontrib><creatorcontrib>Hettiarachchi, Nishani T</creatorcontrib><creatorcontrib>Wilkinson, Jenny A</creatorcontrib><creatorcontrib>Pearson, Hugh A</creatorcontrib><creatorcontrib>Scragg, Jason L</creatorcontrib><creatorcontrib>Lendon, Corinne</creatorcontrib><creatorcontrib>Al-Owais, Moza M</creatorcontrib><creatorcontrib>Kim, Cindy B</creatorcontrib><creatorcontrib>Myers, David M</creatorcontrib><creatorcontrib>Warburton, Philip</creatorcontrib><creatorcontrib>Peers, Chris</creatorcontrib><collection>AGRIS</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Brain research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Boyle, John P</au><au>Hettiarachchi, Nishani T</au><au>Wilkinson, Jenny A</au><au>Pearson, Hugh A</au><au>Scragg, Jason L</au><au>Lendon, Corinne</au><au>Al-Owais, Moza M</au><au>Kim, Cindy B</au><au>Myers, David M</au><au>Warburton, Philip</au><au>Peers, Chris</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cellular consequences of the expression of Alzheimer's disease-causing presenilin 1 mutations in human neuroblastoma (SH-SY5Y) cells</atitle><jtitle>Brain research</jtitle><addtitle>Brain Res</addtitle><date>2012-03-14</date><risdate>2012</risdate><volume>1443</volume><spage>75</spage><epage>88</epage><pages>75-88</pages><issn>0006-8993</issn><eissn>1872-6240</eissn><coden>BRREAP</coden><abstract>Abstract Mutations in the presenilin 1 (PS1) gene lead to early-onset Alzheimer's disease with the S170F mutation causing the earliest reported age of onset. Expression of this, and other PS1 mutations, in SH-SY5Y cells resulted in significant loss of cellular viability compared to control cells. Basal Ca 2 + concentrations in PS1 mutants were never lower than controls and prolonged incubation in Ca 2 + -free solutions did not deplete Ca 2 + stores, demonstrating there was no difference in Ca 2 + leak from endoplasmic reticulum (ER) stores in PS1 mutants. Peak muscarine-evoked rises of [Ca 2 + ]i were variable, but the integrals were not significantly different, suggesting, while kinetics of Ca 2 + store release might be affected in PS1 mutants, store size was similar. However, when Ca 2 + -ATPase activity was irreversibly inhibited with thapsigargin, the S170F and ΔE9 cells showed larger capacitative calcium entry indicating a direct effect on Ca 2 + influx pathways. There was no significant effect of any of the mutations on mitochondrial respiration. Amyloid β(Aβ(1–40)) secretion was reduced, and Aβ(1–42) secretion increased in the S170F cells resulting in a very large increase in the Aβ42/40 ratio. This, rather than any potential disruption of ER Ca 2 + stores, is likely to explain the extreme pathology of this mutant.</abstract><cop>Amsterdam</cop><pub>Elsevier B.V</pub><pmid>22297172</pmid><doi>10.1016/j.brainres.2011.12.061</doi><tpages>14</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0006-8993
ispartof Brain research, 2012-03, Vol.1443, p.75-88
issn 0006-8993
1872-6240
language eng
recordid cdi_proquest_miscellaneous_926507123
source MEDLINE; Elsevier ScienceDirect Journals
subjects Adult and adolescent clinical studies
Alzheimer disease
Alzheimer's disease
amyloid
Amyloid beta-Peptides - metabolism
Amyloid β mitochondria
Biological and medical sciences
brain
Ca2 + homeostasis
calcium
Calcium - metabolism
Cell Line, Tumor
Cell Survival
Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases
endoplasmic reticulum
genes
Humans
Medical sciences
Mitochondria - metabolism
mutants
Mutation
Neurology
Organic mental disorders. Neuropsychology
Presenilin-1 - genetics
Presenilin-1 - metabolism
Psychology. Psychoanalysis. Psychiatry
Psychopathology. Psychiatry
S170F PS1 mutation
secretion
SH-SY5Y
viability
title Cellular consequences of the expression of Alzheimer's disease-causing presenilin 1 mutations in human neuroblastoma (SH-SY5Y) cells
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T13%3A12%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cellular%20consequences%20of%20the%20expression%20of%20Alzheimer's%20disease-causing%20presenilin%201%20mutations%20in%20human%20neuroblastoma%20(SH-SY5Y)%20cells&rft.jtitle=Brain%20research&rft.au=Boyle,%20John%20P&rft.date=2012-03-14&rft.volume=1443&rft.spage=75&rft.epage=88&rft.pages=75-88&rft.issn=0006-8993&rft.eissn=1872-6240&rft.coden=BRREAP&rft_id=info:doi/10.1016/j.brainres.2011.12.061&rft_dat=%3Cproquest_cross%3E926507123%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=926507123&rft_id=info:pmid/22297172&rft_els_id=1_s2_0_S0006899312000042&rfr_iscdi=true